Results 151 to 160 of about 281,573 (395)

Studies in Chronic Lymphocytic Leukemia: Further Studies of the Proliferative Abnormality of the Blood Lymphocyte [PDF]

, 1969
Arnold D. Rubin, K. Havemann, William Dameshek   +2 more
openalex   +1 more source

Cardiovascular Disease Meets Cancer: Exploring the Epidemiology in China and Homotherapy Targeting Intersectional Mechanisms

Advanced Science, EarlyView.
Cardiovascular disease (CVD) and cancer are leading causes of death worldwide, with overlapping risk factors and pathophysiological mechanisms. This review explores shared pathways, including metabolic dysregulation, chronic inflammation, and gut microbiome alterations, highlighting dual‐benefit strategies such as lifestyle modifications and repurposed
Shihan Xiang, Yujie Shan, Shihong Xu, Jing Wang, Meng Luo, Jiaojiao Zhou, Qishan Chen   +6 more
wiley   +1 more source

Differentiation between tuberculosis and leukemia in abdominal and pelvic lymph nodes: evaluation with contrast-enhanced multidetector computed tomography

Clinics, 2015
PURPOSE: To compare the characteristics of tubercular vs. leukemic involvement of abdominopelvic lymph nodes using multidetector computed tomography (CT).
Ge Zhang, Zhi-gang Yang, Jin Yao, Wen Deng, Shuai Zhang, Hua-yan Xu, Qi-hua Long   +6 more
doaj   +1 more source

A Study of Prednisone Therapy in Chronic Lymphocytic Leukemia [PDF]

, 1961
Richard K. Shaw, Dane R. Boggs, H Silberman, Emil Frei   +3 more
openalex   +1 more source

Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia

Nature Communications, 2018
Deciphering the evolution of cancer cells under therapeutic pressure is a crucial step to understand the mechanisms that lead to treatment resistance.
C. Herling, N. Abedpour, J. Weiss, A. Schmitt, R. Jachimowicz, O. Merkel, Maria Cartolano, S. Oberbeck, P. Mayer, Valeska Berg, Daniel Thomalla, N. Kutsch, Marius Stiefelhagen, P. Cramer, C. Wendtner, T. Persigehl, Andreas Saleh, J. Altmüller, P. Nürnberg, C. Pallasch, V. Achter, Ulrich Lang, B. Eichhorst, Roberta Castiglione, S. Schäfer, R. Büttner, K. Kreuzer, H. Reinhardt, M. Hallek, L. Frenzel, M. Peifer   +30 more
semanticscholar   +1 more source

Optimized Monothiol Thioredoxin Derivative (ORP100S) Protects In Vitro and In Vivo from Radiation and Chemotoxicity Without Promoting Tumor Proliferation

Advanced Science, EarlyView.
Native thioredoxin‐1 (TRX) stimulates proliferation and rescues stem cells and cancer cells from multiple stressors by suppressing p53 and inhibiting ferroptosis via GPX4/SLC7A11 upregulation mediated by enhanced KLF4 expression and p53 promoter binding.
Jian Wu, Xiaobei Wang, Parker Mathews, Shaima Jabbar, Min Zhang, Haim Moskowitz, Wei Duan, David P. Nichols, George William Schaaf, John D. Olson, Andrew N. Macintyre, J. Daniel Bourland, Ivan Spasojevic, Jen‐Tsan Ashley Chi, Joel Ross, Nelson Chao, J. Mark Cline, Peter B. Heifetz, Yubin Kang   +18 more
wiley   +1 more source

Brief Report: Infusion of Isologous Immune Plasma in Chronic Lymphocytic Leukemia [PDF]

, 1968
John László, C.E. Buckley, D. Bernard Amos   +2 more
openalex   +1 more source

Tead1a Initiates Transcriptional Priming Through the TEAD1a/YAP‐Notch1‐Spi1/Cebpα Axis to Promote Neutrophil Fate

Advanced Science, EarlyView.
This study discovered that the protein TEAD1a is crucial for neutrophil development. In zebrafish models, disrupting TEAD1a or its interaction with partner protein YAP1 caused severe neutrophil deficiency. TEAD1a functions during the early HSC stage, activates Notch1 signaling in the GMP stage, and triggers Spi1 and Cebpα to drive neutrophil terminal ...
Wang Yiqin, Yang Ruimeng, Wang Peihong, Liu Xiaohui, Yuan Hao, Huang Hongli, Zhou Yongjian, Xie Baoshu   +7 more
wiley   +1 more source

Relation of Bone Marrow Findings to Serum Protein Changes in Lymphosarcoma, Chronic Lymphocytic Leukemia and Hodgkin’s Disease [PDF]

, 1960
Altan Onat, Talbert Cooper
openalex   +1 more source

Nanomaterials Trigger Functional Anti‐Tumoral Responses in Primary Human Immune Cells

Advanced Science, EarlyView.
Nanoparticles are used to improve immunomodulatory therapies, but the impact of drug‐free nanomaterials on the immune system remains unknown. Screening common biomedical nanoparticles (NPs) reveals that PLGA NPs enhanced NK cell anti‐tumoral activity and transcriptional activation in human NK and pan T cells.
Vincent Mittelheisser, Olivier Lefebvre, Mainak Banerjee, Shayamita Ghosh, Amandine Dupas, Marie‐Charlotte Diringer, Juliette Blumberger, Louis Bochler, Sébastien Harlepp, Annabel Larnicol, Angélique Pichot, Tristan Stemmelen, Anne Molitor, Chloé Moritz, Christine Carapito, Raphaël Carapito, Loïc J. Charbonnière, François Lux, Olivier Tillement, Jacky G. Goetz, Alexandre Detappe   +20 more
wiley   +1 more source